• Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=11264164).
  
• Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Thr531Tyrfs*10 (c.1589dup) (p.Thr532Tyrfs*10, c.1592dup); Zygosity=Homozygous (PubMed=35124168).
  
• Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Val1003Ile (c.3007G>A); Zygosity=Heterozygous (PubMed=35124168).
  

PubMed=11264164; DOI=10.1182/blood.V97.7.1999
Kano Y., Akutsu M., Tsunoda S., Mano H., Sato Y., Honma Y., Furukawa Y.
In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents.
Blood 97:1999-2007(2001)

Patent=WO2004094628A1
Sato Y., Nagao H.
Imanitib-resistant Philadelphia chromosome-positive human acute lymphocytic leukemic cell line and utilization thereof.
Patent number WO2004094628A1, 04-Nov-2004

PubMed=29786757; DOI=10.1007/s12185-018-2474-7
Tomoyasu C., Imamura T., Tomii T., Yano M., Asai D., Goto H., Shimada A., Sanada M., Iwamoto S., Takita J., Minegishi M., Inukai T., Sugita K., Hosoi H.
Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
Int. J. Hematol. 108:312-318(2018)

PubMed=35124168; DOI=10.1016/j.jsbmb.2022.106068
Tamai M., Kasai S., Akahane K., Thu T.N., Kagami K., Komatsu C., Abe M., Watanabe A., Goi K., Miyake K., Inaba T., Takita J., Goto H., Minegishi M., Iwamoto S., Sugita K., Inukai T.
Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
J. Steroid Biochem. Mol. Biol. 218:106068.1-106068.12(2022)